P53 activity plays a key role in mammalian cells when they undergo replicative senescence at their Hay¯ick limit. To determine whether p63 proteins, members of the family of p53-related genes, are also involved in this process, we examined their expression in serially passaged rat embryo ®broblasts. Upon senescence, two truncated DNp63 proteins decreased in abundance whereas two TAp63 isoforms accumulated. 2-D gel analysis showed that the DNp63 proteins underwent post-translational modi®cations in both proliferating and senescent cells. Direct binding of DNp63 proteins to a p53 consensus motif was greater in proliferating cells than senescent cells. In contrast p63a isoforms bound to DNA in a p53 dependent manner and this was higher in senescent cells than proliferating cells. An interaction of p63a proteins with SV40 large tumour antigen was also detected and ectopic expression of DNp63a can extend the lifespan of rat embryo ®broblasts. Taken together the results indicate that p63 proteins may play a role in replicative senescence either by competition for p53 DNA binding sites or by direct interaction with p53 protein bound to DNA. Oncogene (2002) 21, 981 ± 989.
Introduction
Most eukaryotic cells have a ®nite proliferative potential in vivo which leads to replicative senescence (Hay¯ick, 1985) with abrogation of this limited mitotic potential proposed as one of the critical steps necessary for cancer progression (Hanahan and Weinberg, 2000) .
The property that distinguishes senescence from other ways in which cells exit the cell cycle, is the irreversibility of the arrest, with no known physiological mitogens able to restimulate cell division (Cristofalo et al., 1989) . In senescence, growth arrest occurs mainly in G 1 or at the G 1 /S boundary (Sherwood et al., 1988) , and in some cases at G 2 (Gonos et al., 1996) .
The senescent phenotype is dominant as cell fusion between diploid ®broblasts and immortal cell lines yields hybrids with a ®nite lifespan (Pereira-Smith et al., 1990) . This dominance is likely to be mediated by proteins with speci®c antiproliferative activities (Pereira-Smith and Smith, 1988) . Candidates include CD inhibitors such as p16 INK4a , p27
Kip1 and p21
Cip1/WAF1/Sdi1 whose expression is up-regulated in senescent cells (Bringold and Serrano, 2000) . Since p53 is an upstream regulator of p21 Cip1/WAF1/Sdi1 and the most frequently mutated gene in human cancer, it is another potential regulator of cellular senescence (el-Deiry et al., 1993) . Indeed, p53 protein expression and transcriptional activity have been shown to be upregulated in human diploid ®broblasts undergoing senescence (Bond et al., 1996) . Furthermore, reinitiation of DNA synthesis and cell division occurs in senescent cells microinjected with anti-p53 antibodies (Gire and Wynford-Thomas, 1998) . The increase in p53 protein level could be due to protein stabilization via interaction with p19 ARF (mouse) or p14 ARF (human) which prevent p53 degradation by antagonizing Mdm2 (Weber et al., 2000) . However, others have found no change in p53 protein level in senescent human ®broblasts, and proposed that increase in activity was due to changes in post-translational modi®cation, since its phosphorylation pattern changed upon senescence and was distinct from that induced by DNA damage (Webley et al., 2000) . Therefore, to overcome senescence p53 activity must be abrogated, either by disruption of function by mutation or inactivation by interaction with oncoproteins such as SV40 large tumour (LT) antigen (Lane and Crawford, 1979) , Adenovirus E1B 58K (Sarnow et al., 1982) or the Human Papillomavirus E6 protein (Werness et al., 1990) .
P63 and p73 are a family of p53-related proteins that share a high amino acid sequence homology in the DNA binding domain (Yang et al., 1998) . This suggests that they could also be potentially involved in regulating senescence. The expression of these genes is further complicated by the use of alternative promoters and dierential splicing. Dierent p63 splice forms can encode proteins with two dierent amino termini, TA comprising a transactivating domain and DN without the transactivation domain, and three dierent carboxy termini, a, the longest, b and g, the shortest form (Yang et al., 1998) . Some of these splice forms, such as TAp63g, can activate transcription from the p21
Cip1/WAF1/Sdi1 promoter and induce apoptosis (Ishida et al., 2000) , whereas others, like DNp63g, act as inhibitors of p53 and p63 transcriptional activity (Yang et al., 1998) . All splice forms of p63 and p73 have an extended C-terminal region, not found in p53, containing a SAM motif previously identi®ed in other proteins that regulate development (Thanos and Bowie, 1999) . P73 and p63 de®cient mice show developmental abnormalities. The p73 knockout mice have revealed a role for this protein in neurogenesis, sensory pathways and homeostatic control (Yang et al., 2000) , whereas p63 de®cient mice show a failure in ectodermal dierentiation during embryogenesis re¯ected by limb and skin abnormalities (Mills et al., 1999; Yang et al., 1999) . Interestingly, the human p63 gene is mutated in children who suer from EEC (Ectrodactyly, Ectodermal dysplasia and Facial Clefts), a condition similar to the phenotype of p63-de®cient mice (Celli et al., 1999) . In other work, it has been shown that p73d increase and p63 isoforms decrease at the mRNA level when human keratinocytes undergo dierentiation .
If senescence is considered as a cellular phenomenon with similarities to terminal dierentiation where cells undergo irreversible growth arrest but remain viable (Peacocke and Campisi, 1991) , then p63 and p73 could play a role in regulating senescence. We have therefore undertaken a systematic study to examine whether there are changes in expression of p63 isoforms when rat embryo ®broblasts (REFs) undergo senescence upon serial passaging. Four proteins of the p63-family exhibit dierential expression; two dierent TAp63 isoforms accumulated whereas two DNp63 isoforms decreased in abundance. Moreover, we show that the changes in expression correlated with dierential binding to a p53 DNA consensus motif. We also present the ®rst detection of an interaction of p63a proteins with SV40 LT antigen and that DNp63a can extend the lifespan of rat embryo ®broblasts. These results indicate a role for p63 proteins in replicative senescence and cell immortalization.
Results

Differential expression of p63 proteins upon serial passaging
To analyse p63 expression in senescent cells, rat embryo ®broblasts were prepared and serially passaged using the 3T3 protocol until they ceased dividing. Total extracts were prepared from representative cultures at each passage and analysed by Western blotting. To ensure that only changes in expression due to senescence were being examined, extracts were prepared from sub-con¯uent cultures that had been passaged the previous day and thus should not contain quiescent cells. Expression of p63 was determined using three antibodies raised against dierent domains of p63 proteins: 4A4, an anity-puri®ed mouse monoclonal antibody raised against sequences within the DNA binding domain such that it recognizes all p63 proteins; p40, an anity puri®ed rabbit polyclonal antibody directed against the N-terminus 14 aa speci®c to DNp63 and recognizing only DNp63 isoforms; and H-129, an anity puri®ed rabbit polyclonal antibody raised against the carboxy terminus domain of a isoforms and speci®c for p63a isoforms. None of these p63 antibodies cross react with p53 or p73.
Western blots with 4A4 ( Figure 1a ) detected four proteins of 90, 65, 60 and 51 KDa that were dierentially expressed in REFs upon serial passaging. Expression of the 90 and 51 KDa proteins was upregulated whereas the 65 and 60 KDa proteins were downregulated ( Figure 1a , lanes 1 ± 4). The 90 KDa protein comigrated with TAp63a transiently expressed in p537/7 cells (lane 6). This protein was also detected by Western blotting with H-129 (Figure 1c ), indicating that it was an a isoform, but as expected it was not detected by the p40 antibody. The p51 KDa protein has been previously described as TAp63g (Katoh et al., 2000) and consequently was not detected by either H-129 or p40 (compare Figure 1a with b and c). In contrast, both of the down-regulated 60 and 65 KDa proteins were detected by the p40 antibody indicating that they were DNp63 isoforms (Figure 1b) . However, when these extracts were analysed with the H-129 antibody, only the 60 KDa protein was identi®ed (Figure 1c ) demonstrating that the 60 KDa protein was an a isoform. Since this protein migrated faster than the authentic full-length 60 KDa DNp63a (compare lane 1 with 5 in Figure 1a ), it must correspond to an additional as yet unidenti®ed variant. The 65 KDa protein was detected by 4A4 ( Figure 1a ) and p40 (Figure 1b) but not H-129 (Figure 1c ), indicating it was DNp63 but not an a isoform. The most likely candidate for this protein is DNp63b. H-129 detected other bands (Figure 1c ) that were dierentially expressed upon passaging but further experiments are necessary to determine their identity.
Thus replicative senescence was associated with dierential expression of four members of the p63-family of proteins, two TAp63 and two DNp63 isoforms respectively.
4A4, H-129 and p40 antibodies detect multiple modified forms of p63 on 2D-gel electrophoresis (2-DE)
To further analyse the dierential expression of the p63-family of proteins, equal amounts of extracts from early passage (P2) and late passage (P5) senescent Immunoblotting of P2 extracts with the 4A4 antibody detected a prominent train of ®ve spots which corresponded to the 65 KDa protein detected on 1-D gels. When P5 extracts were blotted with 4A4, all of the spots showed a decreased intensity. Furthermore, there was a change in the pro®le as the most intense spot in P2 was spot 3 whereas in P5, it was spot 2 (compare panel`a' with`b' in Figure  2a ), indicating that the relative proportions of the 65 KDa forms diered between growing and senescent cells.
When the ®lters were reprobed with the p40 antibody, the same constellation of spots for the 65 KDa protein detected by 4A4 were identi®ed. Moreover, in P2 extracts spot 3 was again the major spot, whereas in P5 only spot 2 was detected and the spots showed the same large decrease in intensity (Figure 2b panels a,b). This result again con®rmed the 1-D Western blot results and indicated that these spots were clearly modi®ed forms of a DNp63 isoform that diered in abundance between P2 and P5. In addition, the p40 antibody detected the 60 KDa protein as a single spot only in the P2 extracts ( Figure  2b ). This spot corresponded to the most intense spot out of a group of four spots detected by the H-129 antibody for the 60 KDa protein in P2 extracts (Figure 2c panel a) . When P5 extracts were blotted with H-129, the intensity of the 60 KDa spots was decreased and only a single spot that corresponded to the most intense spot in P2 was detected (Figure 2c panel b). As for the 65 KDa protein, the 60 KDa protein was detected as a train of spots with the same molecular weight but slightly dierent isoelectric points, indicating that this protein also undergoes post-translational modi®cation. Western blotting of the 2-D gels therefore con®rmed that the 65 and 60 KDa proteins were down-regulated when REFs underwent senescence and indicated that the relative proportions of the modi®ed forms of the 65 KDa protein changed with serial passaging.
p63-protein bind to a p53 consensus motif EMSA were performed to determine whether dierential expression of the p63-family of proteins correlated with changes in DNA-binding activity to a p53 consensus motif. The results presented in Figure  3a , lanes 1 and 2, show the presence of a band shift designated`shift A' with a higher intensity in nuclear extracts from P5 compared to P2. When the extracts were pre-incubated with PAb421, a monoclonal antibody speci®c for p53, this band disappeared and gave rise to a super-shift indicating that the majority of this shift must correspond to binding of p53 (Figure 3a , lanes 3 and 4). PAb421 antibody has previously been shown to be capable of enhancing the DNA binding activity of p53. This result was reproduced in Figure 3b (lanes 1, 2, 5 and 6) and Figure 3c (lanes 1 and 2) . This shift was not detected in gel shift assays carried out with extracts from p537/7 cells con®rming that it was due to binding of p53 (Figure 3b, lanes 3 and 7) . However, since the dierential in shift`A' between P2 and P5 was reduced by both H-129 (Figure 3a , lanes 5 and 6) and p40 (Figure 3b, lanes 9 and 10) , it suggested that some p63 proteins may be present within this complex at a low level. This was further supported when extracts were pre-incubated with both PAb421 and H-129 and some of the PAb421 super-shifted complex was double-super-shifted as a result of H-129 binding to the DNA-protein-PAb421 complex ( Figure  3a, lanes 7 and 8) . This complex could be a Figure 3 DNA-binding activity of p63 proteins on a p53 consensus motif. (A) EMSA were performed using nuclear extracts from P2 and P5 REFs. Nuclear extracts were preincubated with either PAb421 (lanes 3 and 4), H-129 (lanes 5 and 6) or both antibodies (lanes 7 and 8). (B) EMSA performed with nuclear extracts from P2 and P5 REFs, p537/7 and p53+/+ cells. Nuclear extracts were preincubated with either PAb421 (lanes 5 ± 7) or p40 (lanes 9 ± 12). (C) A higher contrast picture of lanes 1, 2 and 3 in panel B p63 proteins and replicative senescence S Djelloul et al heterotetramer of p53 and p63a bound to both PAb421 and H-129 antibodies. This indicated that p63a proteins can bind to the p53 DNA consensus motif via p53 and that this binding activity was dierential between P2 and P5 cells. Since shift`A' was also aected by the p40 antibody, it is likely that DN proteins may also be present in these heteromeric complexes. In addition to shift`A', another shift designated`B', with a higher intensity in P2 in comparison to P5 extracts was observed (Figure 3a,b,c, lanes 1 and 2) . Pre-incubation of extracts with H-129 alone or PAb421 with H-129 did not aect this shift (Figure 3a, lanes  3 ± 8) . In contrast when the extracts were pre-incubated with p40, shift`B' disappeared and a new super-shift appeared in both P2 and P5 (Figure 3b, lanes 9 and  10) . This super-shift of`B' with the p40 antibody was also observed in both p537/7 and p53+/+ extracts ( Figure 3b , lanes 11 and 12) indicating that shift`B' was due to binding to DNp63 proteins, which were present at a higher level in P2 than P5 cells and that this binding was independent of p53.
These results indicate that p63a isoforms interact with the p53 consensus motif in a p53-dependent manner whereas DNp63 isoforms are capable of direct interaction. Moreover, in accordance with the expression data for DNp63 and TAp63a, there was more DNp63 binding to DNA in P2 than P5 whereas p63a binding was greater in P5 compared to P2.
p63a proteins interact with SV40 LT antigen
Since p63 proteins are homologous to p53 within the DNA binding domain that is required for binding SV40 LT antigen, we undertook experiments to determine if p63a proteins could interact with SV40 LT antigen. To explore this possibility, the tsa14 cell line, a cell line derived by immortalizing REFs with the thermolabile tsA58 LT antigen was used (Jat and Sharp, 1989) . It is immortal at 338C and undergoes senescence at 39.58C upon inactivation of tsA58 LT antigen. Protein extracts of tsa14 cells at 338C and 39.58C, were immunoprecipitated with H-129, H-137 and 4A4. H-137 is an anity puri®ed rabbit polyclonal antibody raised against sequences within the DNA binding domain and thus like 4A4 interacts with the amino terminal DNA binding domains of all p63 isotypes. The immunoprecipitated proteins were blotted with PAb416, a LT antigen speci®c mouse monoclonal antibody (Harlow et al., 1981) . Since p53 interacts with LT antigen (Lane and Crawford, 1979) , extracts were immunoprecipitated with PAb421 as a positive control. The results show that H-129, in contrast to H-137 and 4A4, coprecipitated LT antigen from tsa14 cell extracts prepared at 338C (Figure 4a ). This result was analogous to the coprecipitation of LT antigen by 421 at 338C and not at 39.58C due to inactivation of LT antigen.
To determine whether H-129 immunoprecipitated p63a proteins bound LT antigen via p53, we transiently transfected a LT antigen construct into mouse p537/7 cells that express p63a, and analysed the interaction. As a positive control, mouse p53+/+ cells were transiently transfected with the same LT expression vector. Protein A-sepharose alone was used as a negative control and PAb421 was used as a positive control (Figure 4b ). We also analysed the expression level of LT antigen and p53 induced upon transient expression by direct Western blotting (Figure 4c) . Immunoprecipitation with H-129 brought down LT antigen from both p53++ and p537/7 cells transfected with the LT expression construct ( Figure  4b) ; the amount of LT antigen precipitated from p537/7 cells was considerably lower than that from p53+/+ cells (Figure 4b ). However, this was in accordance with the lower amount of LT expressed in p537/7 cells compared to p53+/+ (Figure 4c ). H-129 also coprecipitated LT antigen from mouse p537/7 cells transfected with both LT and a mouse p53 expression construct (data not shown). Surprisingly, when extracts from p537/7 cells transfected with LT antigen alone were precipitated with a mixture of PAb421 and H-129, much more LT antigen was precipitated. This is most likely to be the result of an Extracts from tsa14 cells cultured at 338C and 39.58C were immunoprecipitated with the indicated antibodies and analysed by Western blotting using the LT antigen speci®c monoclonal antibody PAb416. Protein A-sepharose (C) and normal rabbit serum (NRS) were used as negative controls for the immunoprecipitation. (B) Mouse p53+/+ and p537/7 were transfected with an SV40 LT expression vector and lysed 48 h after transfection. Cell extracts were immunoprecipitated with either Protein G beads alone or with H-129, PAb421 or both antibodies and Western blotted using PAb416. (C) Extracts prepared from transient transfections for immunoprecipitation were analysed by direct Western blotting to quantify the level of LT antigen (PAb416) and p53 protein (PAb421) Oncogene p63 proteins and replicative senescence S Djelloul et al association between LT antigen, p63a and another PAb421 epitope-positive p53 homologue. These results showed that p63a proteins were capable of interacting with SV40 LT antigen, albeit weakly, in a p53 independent manner. However further experiments are necessary to determine if this interaction is direct or mediated via another protein.
DNp63a extends life span of REFs
Our observation that the level of DNp63 proteins decreased when REFs were serially passaged suggested the possibility that they may be positive modulators of cell proliferation. To investigate this we determined whether DNp63a would extend the lifespan of secondary REFs. As a positive control, p53GSE, a 93 amino acid fragment of p53 that has been shown to act as a dominant negative for p53 (Ossovskaya et al., 1996) was used. In all three experiments shown in Table 1 , we found that DNp63a gave an increase in the number of colonies with respect to vector alone and the colonies were larger in size suggesting that DNp63a was able to extend the lifespan of REFs. However none of these colonies could be expanded into cell lines indicating that DNp63a alone was insucient for their immortalization.
Discussion
Analysis of p63 proteins that correspond to the extended family of p53-related proteins, has identi®ed four members of this family that show changes in protein expression in REFs when they undergo replicative senescence upon serial passaging. Two proteins that correspond to TAp63a (90 KDa) and TAp63g (51 KDa) were found to accumulate, whereas another two proteins of 60 and 65 KDa respectively were found to decrease. The 60 KDa protein is a novel isoform of DNp63a whereas the 65 KDa protein is also a DNp63 but not an a isoform. Moreover, DNp63 proteins can bind directly to a p53 consensus motif whereas p63a isoforms bind to DNA in a p53 dependent manner, and these interactions are dierential between proliferating and senescent cells. We also present the ®rst detection of an interaction of p63a proteins with SV40 LT antigen, and further show that DNp63a was able to extend the life span of REFs.
Immunoblotting with the 4A4 antibody identi®ed four p63 proteins that show changes in expression level. Since the p40 antibody recognized both proteins that decreased in their expression level, it indicated that they were both DNp63 isoforms. Moreover, the 60 KDa protein was recognized by H-129, indicating that it was an a isoform but smaller than the authentic full-length 68 KDa DNp63a. Various additional splice forms have been described by Hall and colleagues and explained by the existence of multiple splice variants (Hall et al., 2000) ; the 60 KDa DNp63a may be one such splice variant. The most likely candidate for the 65 KDa protein is DNp63b (Yang et al., 1998) . The identity of the two proteins that accumulate was easier to determine. The 90 KDa protein co-migrated with transiently expressed TAp63a and was recognized by H-129, the a speci®c antibody, in addition to 4A4 but not by p40. The 51 KDa protein most probably corresponds to TAp63g since it was not recognized by H-129 or p40 and a 51 KDa protein has been previously identi®ed as TAp63g (Katoh et al., 2000) .
DNp63 proteins have been suggested to be capable of dominantly repressing the transcriptional activation activity of both p63 and p53 (Yang et al., 1998) . Moreover DNp63a was found to be expressed at a higher level in proliferating cells in comparison to nonproliferating cells (Hall et al., 2000) . Our ®nding that both the 60 and 65 KDa proteins were down-regulated when REFs underwent replicative senescence are consistent with these results, even though their exact identity remains to be determined. The decrease in DNp63 proteins correlated with a decrease in DNp63 mRNA level as determined by semi-quantitative RT ± PCR (data not shown). The accumulation of the TAp63a and g that we observed upon replicative proteins are involved in cell cycle arrest and cell dierentiation .
It has been proposed that p53 activity in senescence is modulated by phosphorylation (Webley et al., 2000) . We therefore examined whether p63 proteins undergo post-translational modi®cation in both growing and senescent cells. Western blotting of 2-D gels identi®ed a constellation of spots that corresponded to the 65 and 60 KDa proteins. The constellation of spots were made up of a train of spots that migrated at the same molecular weight but dierent isoelectric points corresponding to post-translational modi®cations; a decrease in isoelectric point towards an acidic pH is considered to be due to proteins undergoing phosphorylation. Both groups of spots were reduced in intensity in senescent cells in comparison to proliferating cells. Moreover, the relative proportions of the forms that make up these two proteins were dierent between growing and senescent cells. It is interesting to note that serine 376 in p53, that has been shown to be phosphorylated in senescence is conserved in p63 Secondary REFs were transfected with 5 mg of control vector (pcDNA3) or pcDNA3 encoding DNp63a or pLNCXGSE56 that encodes p53GSE. Forty-eight hours after transfection, REFs were passaged and stable transfectants isolated by selection in 300 mg/ml G418. Transfected REFs were cultured for 2 weeks, representative plates stained and densely staining colonies counted. For each experiment the number of colonies as well as the percentage of control is indicated p63 proteins and replicative senescence S Djelloul et al isotypes, suggesting that it may be a potential phosphorylation site. Analysis of DNA-binding activity using the p53 consensus motif identi®ed two complexes which were both dierential between growing and senescent cells. The slower migrating complex was due to direct binding of DNp63 proteins because it was super-shifted by the DNp63 speci®c antibody but unaected by the p53 or p63a speci®c antibodies. There was more of this complex in growing cells than senescent cells. These results were in accordance with the direct expression analysis and indicated that some DNp63 proteins were down-regulated upon loss of proliferative potential. The most likely candidate for the proteins that gave rise to this complex were the two 65 and 60 KDa DNp63 proteins found to be down-regulated by immunoblotting.
The second faster migrating complex detected in the EMSA was predominantly due to binding of p53. This complex was more prevalent in senescent cells compared to growing cells. The majority of this gel shift must correspond to interaction with p53 because it was super-shifted by pre-incubation with the p53 speci®c antibody 421. However this complex must contain some p63a proteins because pre-incubation with the p63a speci®c antibody H-129 alone resulted in loss of the dierential between P2 and P5 even though no super-shift was observed, whereas pre-incubation with both PAb421 and H-129 resulted in a double super-shift. This indicated that p63a proteins were also able to bind to the p53 consensus sequence but in a p53-dependent manner, and that there was more of this complex in senescent cells in comparison to growing cells. This result was again in accordance with the direct expression analysis where we found that 90 KDa TAp63a protein was upregulated upon senescence and suggested that the 90 KDa TAp63a protein was the most likely candidate that gave rise to this complex. Moreover since pre-incubation with a combination of PAb421 and H-129 super-shifted the complex, it suggested that the 90 KDa TAp63a was able to bind to p53-DNA complexes. It was also likely that this faster migrating complex contains some DNp63 protein because the dierential between growing and senescent cells was also lost upon pre-incubation with p40, the DNp63 speci®c antibody. The identity of this DNp63 isoform remains to be determined because we have not yet identi®ed a DNp63 protein that is upregulated upon senescence.
It has been reported that the oligomerization domain that is conserved in sequence and threedimensional structure in all p53-family members, can mediate interactions between multiple splice variants from an individual gene but is not sucient for interaction with other family members (Arrowsmith, 1999) . Recently co-immunoprecipitation experiments have shown that DNp63a interacts with wild type and some p53 mutants through the core domains, as was shown previously for homo-oligomerization of p53 (Ratovitski et al., 2001) . However, others have demonstrated a correlation between the reactivity of p53 with the 240 antibody and its ability to bind other homologues, implying that p53 can only interact with p63 proteins when it adopts the mutant conformation (Gaiddon et al., 2001) . Since it is known that wild type p53 can adopt the mutant conformation when bound to DNA (Halazonetis et al., 1993) , it supports our observation that p63a and possibly DNp63 bind to p53-DNA complexes.
We have also found that p63a proteins can interact with SV40 LT antigen albeit weakly, in a p53 independent manner. It is likely to be mediated by the DNA binding domain that is highly conserved between p53 and all p63 family members, suggesting that they should all be able to interact with LT antigen. The H-129 antibody directed against the C-terminal domain of p63a was able to coprecipitate LT antigen, whereas neither of the amino-terminal antibodies were able to coprecipitate. This raised the possibility that the epitopes seen by amino-terminal antibodies were masked by protein interactions. There has been one previous report where in vitro translated p51A/p63g was used to determine if it would bind SV40 LT antigen in Cos-7 extracts, and no interaction between these two proteins was detected (Roth and Dobbelstein, 1999) . As p63a represents a longer version of p63g, with an extended C-terminus domain, this extension domain might be important for the interaction with LT antigen. Since LT antigen is known to inhibit p53 activity, the interaction of LT with p63a proteins might similarly modulate their activities. Unfortunately we have not yet been able to identify which a isoform of p63 binds to LT antigen.
Our observation that DN isoforms were downregulated as cells ceased proliferating, together with the ®nding that DNp63 can bind directly to p53 consensus DNA binding sites, suggested that DN isoforms may be positive regulators of cell growth. This was consistent with the observation that DNp63a was able to both increase the number of colonies and their size, suggesting that it could extend the lifespan of REFs. However, it was not sucient alone for their immortalization, indicating that other additional activities were required. Interestingly the C-terminal domain of SV40 LT antigen which can sequester p53, has also been shown to extend the lifespan of rat embryo ®broblasts, but is not sucient for immortalization (Conzen and Cole, 1995; Powell et al., 1999) .
Taken together, the results allow us to propose a model where dierential expression of p63 splice forms in proliferating versus senescent cells modulates p53 activity, either by competition for p53 DNA binding sites or by direct interaction with p53 protein bound to DNA. We suggest that in young proliferating cells, p53 activity is suppressed by the presence of high levels of DNp63 isoforms, whereas it is enhanced in senescent cells by the presence of the TAp63a and g isoforms. Our model is consistent with the ®nding that growing cells have low levels of p21 Cip1/WAF1/Sdi1 whereas senescent cells have high levels of p21
Cip1/WAF1/Sdi1 . It is also supported by the data of Yang et al. (1998) showing DNp63g and a can act as dominant negatives for both p63g and p53 transactivation activity. It is further supported by the work of Crook et al. (2000) who have found that high level expression of DNp63 can inactivate p53 wild type function.
Materials and methods
Cell lines and primary cultures
REFs were prepared from 12 ± 13-day-old Sprague-Dawley rat embryos, maintained and serially passaged as described previously (Ikram et al., 1994) .
Plasmids and DNA transfections
Full-length cDNAs, created by PCR, encoding the rat homologues of DNp63a and TAp63a were inserted into the pcDNA3 expression vector (Invitrogen) and transfected using FuGENE 6 reagent (Roche).
Western blot analysis
Protein extracts were prepared and analysed by immunoblotting using standard procedures (Harlow and Lane, 1988) . Filters were stained with india ink to control for equal loading. PAb421, was puri®ed from hybridoma supernatant by Cymbus Biotechnology Ltd. 4A4, H-129 and H-137 antibodies were from Santa Cruz and p40 antibody from Oncogene Science. Western blotting with secondary antibodies alone was performed to control for non-speci®c binding.
2-Dimensional gel electrophoresis (2-DE)
2-DE was performed by standard procedures as previously described (Stulik et al., 1997) . Commercial Immobiline DryStrip IEF strips with non-linear immobilized pH 3-10 or ReadyStrip linear pH3-6 gradient, were used for isoelectric focusing. Two hundred mg protein per strip, in the ®rst dimension. Fractionated proteins visualized by Western blotting.
Immunoprecipitation analysis
Equal amounts of protein cell lysates prepared in NP40 lysis buer were immunoprecipitated using appropriate antibodies, fractionated and Western blotted (Harlow and Lane, 1988) .
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared as described previously (Lassar et al., 1991) . A 56-mer oligonucleotide containing the p53 consensus binding site (GTGAGTGTTGGAGAA-TATGGACATGCCCAGGCATGTCTGAGGTTAGTA-CTCGCTGC) was used to synthesise the 32 P-labelled doublestrand target DNA. The EMSA were carried out by standard procedures (Lassar et al., 1991) . For super-shift assay, nuclear extracts were pre-incubated with 2 mg puri®ed antibody before EMSA.
